FLUDARABINE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fludarabine Phosphate, and what generic alternatives are available?
Fludarabine Phosphate is a drug marketed by Actavis Llc, Actavis Totowa, Areva Pharms, Extrovis, Fresenius Kabi Usa, Hikma, Hospira, Rising, Sagent Pharms Inc, and Sandoz. and is included in eleven NDAs.
The generic ingredient in FLUDARABINE PHOSPHATE is fludarabine phosphate. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fludarabine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fludarabine Phosphate
A generic version of FLUDARABINE PHOSPHATE was approved as fludarabine phosphate by HIKMA on August 28th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUDARABINE PHOSPHATE?
- What are the global sales for FLUDARABINE PHOSPHATE?
- What is Average Wholesale Price for FLUDARABINE PHOSPHATE?
Summary for FLUDARABINE PHOSPHATE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Clinical Trials: | 484 |
| Patent Applications: | 4,096 |
| DailyMed Link: | FLUDARABINE PHOSPHATE at DailyMed |
Recent Clinical Trials for FLUDARABINE PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fred Hutchinson Cancer Center | Phase 2 |
| National Cord Blood Network | Phase 2 |
| University Cancer Research Fund at Lineberger Comprehensive Cancer Center | Phase 1/Phase 2 |
Pharmacology for FLUDARABINE PHOSPHATE
| Drug Class | Nucleoside Metabolic Inhibitor |
| Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for FLUDARABINE PHOSPHATE
US Patents and Regulatory Information for FLUDARABINE PHOSPHATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Llc | FLUDARABINE PHOSPHATE | fludarabine phosphate | INJECTABLE;INJECTION | 203738-001 | Feb 28, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | FLUDARABINE PHOSPHATE | fludarabine phosphate | INJECTABLE;INJECTION | 076349-001 | Aug 28, 2003 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Extrovis | FLUDARABINE PHOSPHATE | fludarabine phosphate | INJECTABLE;INJECTION | 200647-001 | Dec 21, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
